Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p

被引:64
作者
Tuhkanen, H
Anttila, M
Kosma, VM
Ylä-Herttuala, S
Heinonen, S
Kuronen, A
Juhola, M
Tammi, R
Tammi, M
Mannermaa, A
机构
[1] Univ Kuopio, Dept Pathol & Forens Med, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Clin Genet, SF-70210 Kuopio, Finland
[3] Univ Kuopio, Dept Gynecol & Obstet, FIN-70211 Kuopio, Finland
[4] Univ Tampere, Ctr Lab Med, Dept Pathol, FIN-33101 Tampere, Finland
[5] Tampere Univ Hosp, Tampere, Finland
[6] Univ Kuopio, AI Virtanen Inst, Dept Mol Med, FIN-70211 Kuopio, Finland
[7] Jyvaskyla Cent Hosp, Dept Gynecol & Obstet, Jyvaskyla, Finland
[8] Jyvaskyla Cent Hosp, Dept Pathol, Jyvaskyla, Finland
[9] Univ Kuopio, Dept Anat, FIN-70211 Kuopio, Finland
关键词
allelic imbalance; chromosome; 3p; ovarian cancer; epithelium; stroma;
D O I
10.1002/ijc.11733
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Stromal accumulation of hyaluronan in epithelial ovarian cancers is an independent predictor of tumor spreading and unfavorable outcome of the disease. We started to screen for chromosomal causes of this accumulation by studying deletions in 3p21.3, a region harboring 3 hyaluronidase genes (HYAL1-3) among other potentially important tumor suppressors. Using 6 microsatellite markers from this region, allelic imbalance was found in 60-87% of the informative tumor cells microdissected from histologic sections of 58 patients with epithelial ovarian cancer. However, adjacent stromal cells originally intended as controls showed allelic imbalance at a frequency almost as high as the tumor cells (52-80%). A further laser capture microdissection on 10 borderline tumors also showed a high rate of allelic imbalance, both in the epithelial and stromal cells, but with a pattern slightly different from cancers. Allelic imbalance in the tumor epithelium or stroma was not correlated with the accumulation of hyaluronan or clinicopathologic parameters, including tumor stage and grade. The results suggest that factors other than inactivation of the HYAL1-3 genes are responsible for hyaluronan accumulation in epithelial ovarian tumors. Moreover, the results indicate that the stromal cells of the epithelial ovarian cancers not only respond to the signals from malignant epithelium but also have themselves undergone genetic alterations in markers partly identical to those in the cancer epithelial cells and may actively contribute to the development of the tumor from its early stages to the late determinants of patient mortality. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 49 条
[1]   Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours [J].
Agathanggelou, A ;
Honorio, S ;
Macartney, DP ;
Martinez, A ;
Dallol, A ;
Radar, J ;
Fullwood, P ;
Chauhan, A ;
Walker, R ;
Shaw, JA ;
Hosoe, S ;
Lerman, MI ;
Minna, JD ;
Maher, ER ;
Latif, F .
ONCOGENE, 2001, 20 (12) :1509-1518
[2]  
Anttila MA, 2000, CANCER RES, V60, P150
[3]   Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival [J].
Auvinen, P ;
Tammi, R ;
Parkkinen, J ;
Tammi, M ;
Ågren, U ;
Johansson, R ;
Hirvikoski, P ;
Eskelinen, M ;
Kosma, VM .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02) :529-536
[4]  
Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254
[5]  
Birchmeier C, 1996, ACTA ANAT, V156, P217
[6]   Hyaluronan expression in differentiated thyroid carcinoma [J].
Böhm, J ;
Niskanen, L ;
Tammi, R ;
Tammi, M ;
Eskelinen, M ;
Pirinen, R ;
Hollmen, S ;
Alhava, E ;
Kosma, VM .
JOURNAL OF PATHOLOGY, 2002, 196 (02) :180-185
[7]  
Canzian F, 1996, CANCER RES, V56, P3331
[8]   The six hyaluronidase-like genes in the human and mouse genomes [J].
Csoka, AB ;
Frost, GI ;
Stern, R .
MATRIX BIOLOGY, 2001, 20 (08) :499-508
[9]   Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 [J].
Dammann, R ;
Li, C ;
Yoon, JH ;
Chin, PL ;
Bates, S ;
Pfeifer, GP .
NATURE GENETICS, 2000, 25 (03) :315-319
[10]  
Donjacour A A, 1991, Cancer Treat Res, V53, P335